查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1871921

全球治療性虛擬實境市場：預測至 2032 年—按組件、技術、應用、最終用戶和地區分類的分析

Virtual Reality in Therapy Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software and Services), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球治療性虛擬實境市場價值將達到 32 億美元，到 2032 年將達到 83 億美元，在預測期內的複合年成長率為 14.6%。

治療性虛擬實境（VR）是指利用身臨其境型電腦生成環境來治療心理、神經和生理健康問題。患者可以參與受控的互動式模擬，這些模擬旨在促進情緒調節、認知復健、疼痛管理和運動功能恢復。透過在安全、可自訂的環境中複製真實世界場景，VR療法可以幫助患者克服恐懼、練習應對策略並參與指導下的復健訓練。這項技術融合了臨床心理學、神經科學和數位創新，提供更具沉浸感和可衡量的治療體驗。最終，它能夠提高患者參與度、治療依從性以及心理健康和復健領域的整體復健效果。

人們對心理健康的認知不斷提高

全球對焦慮、創傷後壓力症候群（PTSD）和憂鬱症心理健康問題的日益關注，正在推動虛擬實境（VR）治療技術的應用。隨著社會努力消除對心理健康治療的偏見，醫療服務提供者正轉向身臨其境型VR解決方案，以增強患者參與度並改善治療效果。各國政府和組織正在投資建立數位心理健康基礎設施，支持創新治療工具，從而提高治療的可近性和可負擔性。人們對心理健康護理的日益接受以及對整體健康的關注，正顯著推動全球對基於VR的治療性介入的需求。

高成本設備

虛擬實境硬體、軟體和技術整合的高成本是限制市場發展的主要阻礙因素。先進的VR頭戴裝置、動作感測器和專用程序需要大量投資，這使得小規模醫療機構和個人執業者難以負擔。此外，維護和定期軟體更新也增加了營運成本。虛擬實境治療的保險覆蓋範圍有限也阻礙了其廣泛應用。這些經濟障礙正在減緩市場滲透，尤其是在發展中地區。

技術進步

虛擬實境硬體、人工智慧和運動追蹤技術的持續進步為市場擴張創造了強勁機會。更高的視覺保真度、更佳的觸覺回饋和更低的延遲，使虛擬實境體驗更具沉浸感，臨床療效也更顯著。人工智慧和數據分析的融合，實現了對每位患者康復進展的即時監測和個人化治療方案的發展。此外，價格親民且便攜的虛擬實境設備的開發，也推動了其在醫院的廣泛應用。這些創新正迅速推動虛擬實境成為全球主流治療工具。

資料隱私問題

資料隱私和安全問題對治療性虛擬實境市場構成日益嚴重的威脅。隨著虛擬實境系統收集敏感的患者數據，例如行為反應、生物識別和情緒回饋，資料外洩和未授權存取的風險也隨之增加。遵守諸如 HIPAA 和 GDPR 等醫療保健隱私法規，進一步增加了實施的複雜性。網路安全措施不足會削弱病患的信任，並延緩科技的普及。企業必須投資先進的加密技術和安全的資料管理系統，以確保資料保密性，並建立病患對基於虛擬實境的治療解決方案的信任。

新冠疫情的影響：

新冠疫情顯著加速了虛擬實境技術在治療領域的應用，提升了遠端醫療和數位心理健康解決方案的重要性。由於面對面治療受限，虛擬實境技術已成為提供身臨其境型和互動式治療體驗的關鍵工具。醫療服務提供者利用虛擬實境技術幫助隔離患者應對焦慮、孤獨和復原挑戰。疫情也促進了遠距治療技術的創新和投資，使其更易於取得且價格更親民。

預計在預測期內，恐懼症治療領域將佔據最大的市場規模。

預計在預測期內，恐懼症治療領域將佔據最大的市場佔有率。這主要歸功於虛擬實境（VR）在暴露療法中的有效性。在虛擬環境中，患者可以在專家的指導下，在安全可控的環境中面對恐懼，例如恐懼症高症、飛行恐懼症和社交恐懼症。這項技術能夠在避免現實世界風險的前提下，帶來可衡量的進步，進而改善治療效果。越來越多的臨床證據支持基於VR的恐懼症治療，加上人們對心理健康意識的提高以及身臨其境型技術的普及，預計未來幾年該領域的領先地位將進一步鞏固。

預計在預測期內，研究機構板塊的複合年成長率將最高。

預計在預測期內，研究機構板塊將實現最高成長率，因為臨床研究中心正在增加對虛擬實境（VR）技術的投資，用於認知行為療法、復健和神經療法研究。 VR與神經科學和心理分析的融合，有助於更好地理解大腦反應和治療效果。政府機構的資助以及與科技公司的合作，正在加速基於VR的臨床應用領域的創新。不斷完善的研究驗證將進一步推動虛擬實境解決方案在全球醫療保健領域的商業化應用。

佔比最大的地區：

由於醫療數位化進程的快速發展、政府的大力主導以及人們對心理健康問題的日益關注，亞太地區預計將在預測期內保持最大的市場佔有率。中國、日本、韓國和印度等國家正大力投資先進的醫療技術和遠端醫療平台。該地區不斷完善的醫療基礎設施、大規模的患者群體以及不斷成長的可支配收入都在支撐市場成長。此外，本地虛擬實境（VR）開發商的日益增多以及研究合作的不斷加強，也進一步鞏固了亞太地區在虛擬實境治療行業的領先地位。

預計年複合成長率最高的地區：

在預測期內，由於強勁的技術創新和數位健康解決方案的早期應用，北美預計將實現最高的複合年成長率。美國和加拿大擁有強大的虛擬實境（VR）開發商、醫療服務提供者和研究機構生態系統，致力於推動身臨其境型療法的發展。人們對心理健康的日益關注以及政府對數位療法的支持正在推動該地區的成長。此外，VR公司與醫療機構之間的合作不斷增強，提高了臨床療效的可及性和檢驗，鞏固了北美在該市場的主導地位。

免費客製化服務：

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
  • 分析材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球治療性虛擬實境市場（按組件分類）

  • 硬體
  • 軟體
  • 服務

6. 全球治療性虛擬實境市場（依技術分類）

  • 非身臨其境型
  • 半身臨其境型
  • 完全身臨其境型

7. 全球治療性虛擬實境市場（按應用分類）

  • 物理治療
  • 恐懼症治療
  • 認知療法
  • 創傷後壓力症候群治療
  • 心理治療
  • 中風復健
  • 疼痛管理
  • 其他用途

8. 全球治療性虛擬實境市場（依最終用戶分類）

  • 醫院和診所
  • 精神健康機構
  • 復健中心
  • 居家醫療
  • 研究所
  • 其他最終用戶

9. 全球治療性虛擬實境市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第11章 公司簡介

  • AppliedVR
  • Oxford VR
  • XRHealth
  • Limbix
  • Psious
  • BehaVR
  • MyndVR
  • Vivid Vision
  • DeepStream VR
  • Neuro Rehab VR
  • Tripp
  • SimX
  • Rendever
  • MindMaze
  • FundamentalVR
Product Code: SMRC32291

According to Stratistics MRC, the Global Virtual Reality in Therapy Market is accounted for $3.2 billion in 2025 and is expected to reach $8.3 billion by 2032 growing at a CAGR of 14.6% during the forecast period. Virtual Reality in Therapy refers to the use of immersive, computer-generated environments to treat psychological, neurological, and physical health conditions. It allows patients to engage in controlled, interactive simulations designed to promote emotional regulation, cognitive rehabilitation, pain management, and motor recovery. By replicating real-world scenarios in a safe, customizable setting, VR therapy helps patients confront fears, practice coping mechanisms, or perform guided rehabilitation exercises. This technology bridges clinical psychology, neuroscience, and digital innovation, offering more engaging and measurable therapeutic experiences. Ultimately, it enhances patient motivation, treatment adherence, and overall recovery outcomes across mental health and rehabilitation disciplines.

Market Dynamics:

Driver:

Rising Mental Health Awareness

The growing global awareness of mental health issues such as anxiety, PTSD, and depression is driving the adoption of virtual reality in therapy. As societies destigmatize mental health treatment, healthcare providers are turning to immersive VR solutions to enhance patient engagement and therapeutic outcomes. Governments and organizations are investing in digital mental health infrastructure, supporting innovative therapy tools that improve accessibility and affordability. This rising acceptance of psychological care and focus on holistic wellness significantly boost the demand for VR-based therapeutic interventions worldwide.

Restraint:

High Equipment Costs

The high cost of virtual reality hardware, software, and technical integration acts as a major restraint for the market. Advanced VR headsets, motion sensors, and specialized programs require significant investment, making them less accessible for smaller healthcare providers or individual practitioners. Additionally, maintenance and regular software updates increase operational expenses. Limited insurance coverage for VR-based therapies further discourages widespread adoption. These financial barriers, particularly in developing regions, slow down market penetration.

Opportunity:

Advancements in technology

Continuous advancements in virtual reality hardware, artificial intelligence, and motion tracking technologies are creating strong opportunities for market expansion. Enhanced visual fidelity, improved haptic feedback, and reduced latency are making VR experiences more immersive and clinically effective. Integration with AI and data analytics enables real-time monitoring and personalized therapy plans tailored to individual progress. Moreover, the development of affordable and portable VR devices is increasing accessibility across hospitals. These innovations are accelerating VR's adoption as a mainstream therapeutic tool globally.

Threat:

Data Privacy Concerns

Data privacy and security concerns pose a growing threat to the virtual reality in therapy market. As VR systems collect sensitive patient data-such as behavioral responses, biometrics, and emotional feedback-risks of data breaches or unauthorized access rise. Compliance with healthcare privacy regulations like HIPAA and GDPR adds complexity to implementation. Inadequate cybersecurity measures can undermine patient trust and delay adoption. Companies must invest in advanced encryption and secure data management systems to ensure confidentiality and build confidence in VR-based therapeutic solutions.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of virtual reality in therapy as remote healthcare and digital mental health solutions gained prominence. With in-person therapy sessions restricted, VR emerged as a vital tool for delivering immersive, interactive treatment experiences. Healthcare providers leveraged VR to manage anxiety, loneliness, and rehabilitation challenges in isolated patients. The pandemic also spurred innovation and investment in teletherapy technologies, expanding accessibility and affordability.

The phobia treatment segment is expected to be the largest during the forecast period

The phobia treatment segment is expected to account for the largest market share during the forecast period, due to effectiveness of VR in exposure therapy. Virtual environments allow patients to confront fears-such as heights, flying, or social situations-in a safe and controlled setting under professional supervision. This method offers measurable progress without real-world risks, improving therapy outcomes. Growing clinical evidence supporting VR-based phobia treatment, coupled with increasing mental health awareness and accessibility to immersive technology, fuels the segment's dominance in the coming years.

The research institutes segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the research institutes segment is predicted to witness the highest growth rate as clinical research centers are increasingly investing in VR technology to study cognitive behavior, rehabilitation, and neurotherapy. The integration of VR with neuroscience and psychology research enables better understanding of brain responses and therapeutic efficacy. Funding from government bodies and collaborations with tech companies are accelerating innovation in VR-based clinical applications. As research validation grows, it drives broader commercialization of virtual reality solutions across healthcare sectors globally.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid healthcare digitalization, strong government initiatives, and increasing awareness of mental health issues. Countries like China, Japan, South Korea, and India are investing heavily in advanced medical technologies and telehealth platforms. The region's expanding healthcare infrastructure, large patient base, and rising disposable incomes support market growth. Additionally, the growing presence of local VR developers and research collaborations further strengthen Asia Pacific's dominance in the virtual reality therapy industry.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong technological innovation and early adoption of digital health solutions. The United States and Canada have a robust ecosystem of VR developers, healthcare providers, and research institutions working to advance immersive therapies. Rising mental health concerns and government support for digital therapeutics propel regional growth. Furthermore, collaborations between VR companies and healthcare organizations continue to enhance accessibility and clinical validation, solidifying North America's leadership in this market.

Key players in the market

Some of the key players in Virtual Reality in Therapy Market include AppliedVR, Oxford VR, XRHealth, Limbix, Psious, BehaVR, MyndVR, Vivid Vision, DeepStream VR, Neuro Rehab VR, Tripp, SimX, Rendever, MindMaze, and FundamentalVR.

Key Developments:

In September 2025, Relief Therapeutics Holding SA and NeuroX Group SA, the successor to MindMaze Group SA, have signed a definitive agreement to merge, creating a publicly-listed, AI-driven neurotherapeutics company to be renamed MindMaze Therapeutics Holding SA.

In June 2022, MindMaze has partnered with University of Auckland to launch their "ESPRESSo" Phase 2 trial, using an immersive neuro-animation system called MindPod within two weeks of stroke onset aimed at boosting upper-limb recovery.

Components Covered:

  • Hardware
  • Software
  • Services

Technologies Covered:

  • Non-immersive
  • Semi-immersive
  • Fully immersive

Applications Covered:

  • Physical Therapy
  • Phobia Treatment
  • Cognitive Therapy
  • PTSD Treatment
  • Psychological Therapy
  • Stroke Rehabilitation
  • Pain Management
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Mental Health Institutions
  • Rehabilitation Centers
  • Homecare Settings
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virtual Reality in Therapy Market, By Component

  • 5.1 Introduction
  • 5.2 Hardware
  • 5.3 Software
  • 5.4 Services

6 Global Virtual Reality in Therapy Market, By Technology

  • 6.1 Introduction
  • 6.2 Non-immersive
  • 6.3 Semi-immersive
  • 6.4 Fully immersive

7 Global Virtual Reality in Therapy Market, By Application

  • 7.1 Introduction
  • 7.2 Physical Therapy
  • 7.3 Phobia Treatment
  • 7.4 Cognitive Therapy
  • 7.5 PTSD Treatment
  • 7.6 Psychological Therapy
  • 7.7 Stroke Rehabilitation
  • 7.8 Pain Management
  • 7.9 Other Applications

8 Global Virtual Reality in Therapy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Mental Health Institutions
  • 8.4 Rehabilitation Centers
  • 8.5 Homecare Settings
  • 8.6 Research Institutes
  • 8.7 Other End Users

9 Global Virtual Reality in Therapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 AppliedVR
  • 11.2 Oxford VR
  • 11.3 XRHealth
  • 11.4 Limbix
  • 11.5 Psious
  • 11.6 BehaVR
  • 11.7 MyndVR
  • 11.8 Vivid Vision
  • 11.9 DeepStream VR
  • 11.10 Neuro Rehab VR
  • 11.11 Tripp
  • 11.12 SimX
  • 11.13 Rendever
  • 11.14 MindMaze
  • 11.15 FundamentalVR

List of Tables

  • Table 1 Global Virtual Reality in Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Virtual Reality in Therapy Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Virtual Reality in Therapy Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 4 Global Virtual Reality in Therapy Market Outlook, By Software (2024-2032) ($MN)
  • Table 5 Global Virtual Reality in Therapy Market Outlook, By Services (2024-2032) ($MN)
  • Table 6 Global Virtual Reality in Therapy Market Outlook, By Technology (2024-2032) ($MN)
  • Table 7 Global Virtual Reality in Therapy Market Outlook, By Non-immersive (2024-2032) ($MN)
  • Table 8 Global Virtual Reality in Therapy Market Outlook, By Semi-immersive (2024-2032) ($MN)
  • Table 9 Global Virtual Reality in Therapy Market Outlook, By Fully immersive (2024-2032) ($MN)
  • Table 10 Global Virtual Reality in Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 11 Global Virtual Reality in Therapy Market Outlook, By Physical Therapy (2024-2032) ($MN)
  • Table 12 Global Virtual Reality in Therapy Market Outlook, By Phobia Treatment (2024-2032) ($MN)
  • Table 13 Global Virtual Reality in Therapy Market Outlook, By Cognitive Therapy (2024-2032) ($MN)
  • Table 14 Global Virtual Reality in Therapy Market Outlook, By PTSD Treatment (2024-2032) ($MN)
  • Table 15 Global Virtual Reality in Therapy Market Outlook, By Psychological Therapy (2024-2032) ($MN)
  • Table 16 Global Virtual Reality in Therapy Market Outlook, By Stroke Rehabilitation (2024-2032) ($MN)
  • Table 17 Global Virtual Reality in Therapy Market Outlook, By Pain Management (2024-2032) ($MN)
  • Table 18 Global Virtual Reality in Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 19 Global Virtual Reality in Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global Virtual Reality in Therapy Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 21 Global Virtual Reality in Therapy Market Outlook, By Mental Health Institutions (2024-2032) ($MN)
  • Table 22 Global Virtual Reality in Therapy Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)
  • Table 23 Global Virtual Reality in Therapy Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 24 Global Virtual Reality in Therapy Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 25 Global Virtual Reality in Therapy Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.